Regional Changes in Bone Area and Bone Mineral Content in Boys with Duchenne Muscular Dystrophy Receiving Corticosteroid Therapy

Journal of Pediatrics

Volumn 156, Issue 3, 2010, Pages

  Crabtree, Nicola J ^a,b   Roper, Helen ^c   McMurchie, Heather ^c   Shaw, Nicholas J ^b  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^c Heart of England Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ARTICLE; BODY HEIGHT; BONE; BONE DENSITY; BONE MINERAL; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; DUCHENNE MUSCULAR DYSTROPHY; HUMAN; LEAN BODY WEIGHT; LUMBAR SPINE; MALE; PRIORITY JOURNAL;

EID: 76749114691     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2009.09.010     Document Type: Article

References (29)

1. Larson C.M., and Henderson R.C. Bone mineral density and fractures in boys with Duchenne muscular dystrophy. J Pediatr Orthop 20 (2000) 71-74
2. Frost H.M. The Mechanostat: a proposed pathogenic mechanism of osteoporoses and the bone mass effects of mechanical and nonmechanical agents. Bone Mineral 2 (1987) 73-85
3. Jones G., and Nguyen T.V. Associations between maternal peak bone mass and bone mass in prepubertal male and female children. J Bone Mineral Res 15 (2000) 1998-2004
4. Shaw N.J., White C.P., Fraser W.D., and Rosenbloom L. Osteopenia in cerebral Palsy. Arch Dis Child 71 (1994) 235-238
5. Ward K.A., Caulton J.M., Adams J.E., and Mughal M.Z. Perspective: cerebral palsy as a model of bone development in the absence of postnatal mechanical factors. J Musculoskelet Neuronal Interact 6 (2006) 154-159
6. Manzur A.Y., Kuntzer T., Pike M., and Swan A. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane Database Syst Rev (2004) CD003725
7. Angelini C. The role of corticosteroids in muscular dystrophy: a critical appraisal. Muscle Nerve 36 (2007) 424-435
8. Quinlivan R., Roper H., Davie M., Shaw N.J., McDonagh J., and Bushby K. Report of a Muscular Dystrophy Campaign funded workshop. Birmingham, UK, January 16th 2004. Osteoporosis in Duchenne muscular dystrophy: its prevalence, treatment and prevention. Neuromuscul Disord 15 (2005) 72-79
9. Bothwell J.E., Gordon K.E., Dooley J.M., MacSween J., Cummings E.A., and Salisbury S. Vertebral fractures in boys with Duchenne muscular dystrophy. Clin Pediatr (Phila) 42 (2003) 353-356
10. Houde S., Filiatrault M., Fournier A., Dube J., D'Arcy S., Berube D., et al. Deflazacort use in Duchenne muscular dystrophy: an 8-year follow-up. Pediatr Neurol 38 (2008) 200-206
11. King W.M., Ruttencutter R., Nagaraja H.N., Matkovic V., Landoll J., Hoyle C., et al. Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy. Neurology 68 (2007) 1607-1613
12. Talim B., Malaguti C., Gnudi S., Politano L., and Merlini L. Vertebral compression in Duchenne muscular dystrophy following deflazacort. Neuromuscul Disord 12 (2002) 294-295
13. Kinali M., Mercuri E., Main M., Muntoni F., and Dubowitz V. An effective, low-dosage, intermittent schedule of prednisolone in the long-term treatment of early cases of Duchenne dystrophy. Neuromuscul Disord 12 Suppl 1 (2002) S169-S174
14. Kiebzak G.M., Leamy L.J., Pierson L.M., Nord R.H., and Zhang Z.Y. Measurement precision of body composition variables using the Lunar DPX-L densitometer. J Clin Densitomet 3 (2000) 35-41
15. National Radiological Protection Board. Living with radiation (2008), National Oncologic Protection Board, Oxon
16. Fewtrell M., Ahmed S.F., Allgrove J., Bishop N.J., Crabtree N.J., Gregory J.W., et al. Bone densitometry in children assessed by dual X-ray absorptiometry: uses and pitfalls. Arch Dis Child 88 (2003) 795-798
17. Crabtree N.J. Interpretation of Paediatric Bone Evaluation by dual energy x-ray absorptiometry (DXA) (2007), University of Birmingham, Birmingham
18. Kroger H., Vainio P., Nieminen J., and Kotaniemi A. Comparison of different models for interpreting bone mineral density measurements using DXA and MRI technology. Bone 17 (1995) 157-159
19. Molgaard C., Thomsen B.L., Prentice A., Cole T.J., and Michaelsen K.F. Whole body bone mineral content in healthy children and adolescents. Arch Dis Child 76 (1997) 9-15
20. Crabtree N.J., Kibirige M.S., Fordham J.N., Banks L.M., Muntoni F., Chinn D., et al. The relationship between lean body mass and bone mineral content in paediatric health and disease. Bone 35 (2004) 965-972
21. Cole T.J., Freeman J.V., and Preece M.A. British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalized likelihood. Stat Med 17 (1998) 407-429
22. Eser P., Frozler A., Zendher Y., Wick L., Knecht H., Denoth J., et al. Relationship between the duration of paralysis and bone structure: a pQCT study of spinal cord injured individuals. Bone 34 (2004) 869-880
23. Van Staa T.P., Leufkens H.G., Abenhaim L., Zhang B., and Cooper C. Use of oral corticosteroids and risk of fractures. June, 2000. J Bone Miner Res 20 (2005) 1487-1494 discussion 6
24. Aparicio L.F., Jurkovic M., and DeLullo J. Decreased bone density in ambulatory patients with duchenne muscular dystrophy. J Pediatr Orthop 22 (2002) 179-181
25. Bianchi M.L., Mazzanti A., Galbiati E., Saraiforger S., Dubini A., Cornelio F., et al. Bone mineral density and bone metabolism in Duchenne muscular dystrophy. Osteoporosis Int 14 (2003) 761-767
26. Ahmed S.F., Horrocks I.A., Patterson T., Zaidi S., Ling S.C., McGrogan P., et al. Bone mineral assessment by dual energy X-ray absorptiometry in children with inflammatory bowel disease: Evaluation by age or bone area. J Pediatr Gastroenterol Nutr 38 (2004) 276-281
27. Van Staa T.P., Geusens P., Bijlsma J.W., Leufkens H.G., and Cooper C. Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 54 (2006) 3104-3112
28. Leonard M.B., Feldman H.I., Shults J., Zemel B.S., Foster B.J., and Stallings V.A. Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome. N Engl J Med 351 (2004) 868-875
29. McDonald D.G., Kinali M., Gallagher A.C., Mercuri E., Muntoni F., Roper H., et al. Fracture prevalence in Duchenne muscular dystrophy. Dev Med Child Neurol 44 (2002) 695-698